Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer

Fig. 4

Serum CPN1 as a potential biomarker to predict chemotherapy effectiveness in IBC patients (Cycle2 vs. Cycle3). A Serum CPN1 as a potential biomarker to predict chemotherapy effectiveness compared with the level of CA153 and CEA by ROC analysis, the AUC of CPN1, CA153and CEA were 0.834, 0.724 and 0.601, P < 0.05. B Serum CPN1 as a potential biomarker to chemotherapy effectiveness compared with the level of CA153 and CEA by ROC analysis in the validation set. The AUC of CPN1, CA153 and CEA were 0.860, 0.720 and 0.602, P < 0.05. C The sensitivity and specificity of serum CPN1, CA153 and CEA for predicting chemotherapy effectiveness in the training set and validation set

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us